AVNT FY2025 SEC EDGAR DEF 14A #49 of 168 in industry

Avient Corp CEO pay ratio

The CEO earned $5.8M in FY2025 against median worker pay of $68,450 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
OH
Filing date
2026-03-27
Industry
Chemicals & Pharmaceuticals
Industry rank
#49/168

Data updated August 2026

Subscribe to Avient Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
85:1
Moderate (Scale: 0–1000:1)
CEO pay
$5.8M
Median worker
$68,450

Answer first

Avient Corp's FY2025 CEO total of $5.8M ranks #863 of 1,423 complete filings; its 85:1 pay ratio ranks #727. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $68,450. Industry placement uses the FY2025 SIC-28 peer cohort (# 49 of 168, 71st percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#863
$5.8M of 1,423 FY2025
Ratio rank
#727
85:1 of 1,423
Industry pct
71st
above the industry median pay ratio

How Avient Corp ranks nationally

Avient Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$5,818,257 39th percentile higher than 39% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Avient Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($5.8M) against pay ratio (85:1) for Avient Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3477847.28104765.11273168317358600.921985518.839.6:152.6:165.5:178.4:191.3:1CEO total payPay ratio (CEO : median worker)Avient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient CorpUsana Health Sciences Inc, CEO total pay: 4319105 · Pay ratio (CEO : median worker): 85:1Usana Health Sciences IncRepligen Corp, CEO total pay: 6114771 · Pay ratio (CEO : median worker): 82:1Repligen CorpSupernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Moderna, Inc., CEO total pay: 20029717 · Pay ratio (CEO : median worker): 89:1Moderna, Inc.Vertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / Ma
Avient Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Avient Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Avient Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
85:1
FY2025
vs prior FY
-27:1
from FY2024 112:1
CEO $ YoY
-16%
$5.8M latest
Filings shown
4
FY2022–2025
Avient Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $9.0M - $52,906 171:1 -
2023 $7.6M -16% $51,761 146:1 -25:1
2024 $6.9M -8.7% $61,637 112:1 -34:1
2025 $5.8M -16% $68,450 85:1 -27:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1122976, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
85:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$5.8M
Companies in Industry
168
vs. Industry Median
Above
#49 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Avient Corp: MID · MID$ pay ratio

Avient Corp's FY2025 ratio 85:1 ranks #49 of 168 Chemicals & Pharmaceuticals filers (71st percentile). the CEO earned 85× the median employee ($68,450) in FY2025.

Median employee $68,450 (PAR-MED); MID · MID$ stamps put about 85 median-wage years per CEO year.

CEO Total Pay

$5.8M

FY2025 Summary Compensation, below median

Pay Ratio

85:1

Near industry median

Avient Corp in the higher Chemicals & Pharmaceuticals third

Avient Corp's FY2025 ratio 85:1 ranks #49 of 168 Chemicals & Pharmaceuticals filers (71st percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Avient Corp's $5.8M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #863 and ratio rank #727 split - treat 85:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$5.8M
Median Employee Pay
$68,450
Pay Ratio
85:1
Filing Date
2026-03-27

Company Info

Ticker
AVNT
CIK
1122976
Industry
Chemicals & Pharmaceuticals
SIC Code
2821
State
OH
View SEC filings →
SEC EDGAR DEF 14A for CIK 1122976, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Avient Corp's FY2025 ratio 85:1 ranks #49 of 168 Chemicals & Pharmaceuticals filers (71st percentile).

Read with Avient Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · MID$ · PAR-MED.

Knife River Corp · MID$

ABS(ceo_total_comp) peer at $5.8M (Δ $3K heavier vs Avient Corp); MODEST · HIGH-MED vs this page's MID · MID$ · PAR-MED.
Myriad Genetics Inc · MID$

ABS(ceo_total_comp) peer at $5.8M (Δ $26K heavier vs Avient Corp); MODEST · HIGH-MED vs this page's MID · MID$ · PAR-MED.
SEADRILL Ltd · MID$

ABS(ceo_total_comp) peer at $5.9M (Δ $34K heavier vs Avient Corp); MID · PAR-MED vs this page's MID · MID$ · PAR-MED.
Riley Exploration Permian, Inc. · MID$

ABS(ceo_total_comp) peer at $5.8M (Δ $36K lighter vs Avient Corp); MODEST · ELITE-MED vs this page's MID · MID$ · PAR-MED.
Usana Health Sciences Inc (SIC 28 pole)

Usana Health Sciences Inc stamps MID · MID$ nearest in-SIC by ABS(pay_ratio) to Avient Corp's MID filing.
National dual ranks · #863/#727

Avient Corp's FY2025 package sits #863 by CEO dollars and #727 by ratio under MID$ · MID.
Pay-equity trends · MID

Avient Corp's MID · PAR-MED stamps sit mid-band - pay-equity trends place the ratio against workforce pay.
Data sourced from SEC EDGAR DEF 14A for Avient Corp (CIK 1122976), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.